The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BackgroundIn unrelated donor allogeneic stem cell transplantation (URD‐SCT), most studies reported that peripheral blood stem cells (PBSC) resulted in higher incidence of acute and/or chronic graft‐versus‐host disease (GVHD) without survival benefits compared with bone marrow (BM). To overcome these shortcomings of PBSC, we have used a risk‐adapted GVHD prophylaxis for patients that received HLA‐matched...
ObjectivesFor patients with acute myeloid leukemia in first complete remission (AML CR1) lacking HLA‐matched sibling donors (MSD), 8/8‐matched unrelated donors (URD) are mostly used in cases with poor‐risk features. For AML CR1 with intermediate cytogenetics, however, the benefit of 8/8‐matched URD should be compared with non‐allogeneic therapies as well as MSD.
MethodsTo address this issue, we assessed...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.